Please enable JavaScript to view the site.

Viewing offline content

Limited functionality available

Dismiss

Services
What's New
Industries
What's New
Insights
What's New
Careers
What's New
US-EN Location: United States-English
Contact us

US-EN Location: United States-English
Contact us

Life Sciences

Across life sciences, you’ll find innovators who are developing therapies, treatments, devices, and cures for society’s most pressing health challenges. Alongside them, you will find Deloitte. We connect the right people, partners, and technologies to orchestrate and deliver the business of science.

Subscribe

All
Solutions
People

Explore our content

Select a filter.

Insert Custom HTML fragment. Do not delete! This box/component contains code that is needed on this page. This message will not be visible when page is activated.
+++ DO NOT USE THIS FRAGMENT WITHOUT EXPLICIT APPROVAL FROM THE CREATIVE STUDIO DEVELOPMENT TEAM +++

Deloitte Platforms Navigation. Do not delete! This box/component contains JavaScript that is needed on this page. This message will not be visible when page is activated.

Featured Highlights

Analysis

Biopharma digital maturity benchmark assessment

How does your company’s tech innovation stack up against the competition?

Take our digital maturity benchmark assessment and use your results to help engineer—and maintain—a competitive advantage.

Find out how your biopharma company’s tech innovation stacks up against its competitors. Take our digital maturity benchmark survey.

Let’s make this work.

To view this video, change your targeting/advertising cookie settings.

Perspectives

Tech Trends 2022: A life sciences perspective

Welcoming digital transformation in life sciences

Blog

Using AI to accelerate clinical trials

How available and scalable AI technologies can speed and improve clinical trials

Tales of Transformation: A Life Sciences and Health Care Podcast Series

Hear how life sciences and health care leaders are adapting to change within the industry.

Deloitte Insights

Rethinking market access

Delivering on the promise of therapeutic innovation

Digital Transformation

Perspectives

Digital transformation in life sciences

How pharma and medtech can shift from doing digital to being digital

Digital transformation is no longer a buzzword—it’s a strategic imperative. How can life sciences companies advance their capabilities and take a more holistic view of their digital strategies?

Deloitte Insights

Biopharma digital transformation

Gaining an edge with leapfrog digital innovation

Biopharma is at a digital innovation inflection point. Organizations face a key choice: decelerate the pace of innovation forced by the pandemic or pursue leapfrog innovation.

Deloitte Insights

Breaking barriers to digitalization in biopharma

The pandemic's impact on R&D and commercial operating models

The COVID-19 pandemic has changed the way biopharma does business, from trials to manufacture to sales. Once things get back to normal, will it be business as usual or will the industry evolve and implement learnings from this period?

Perspectives

How life sciences and health care can improve their cyber posture

A new approach to cyber risk reporting

In October 2020, three US agencies joined forces to issue a stark warning to hospitals and healthcare providers: Ransomware attacks are on the rise—and institutions need to take immediate action to protect themselves.

AI & Cognitive Technologies

Let’s make this work.

To view this video, change your analytics/performance cookie settings.

Perspectives

AI in pharma and life sciences

Discover how AI is transforming pharma

From molecule to market, there are significant benefits to applying artificial intelligence at every stage of the life sciences value chain. Welcome to pharma in The Age of With™.

Perspectives

Patient and HCP data can influence life sciences and health care product development

Life sciences companies can tap into AI and data sets to enhance patient experience

Deloitte Insights

Scaling up AI across the life sciences value chain

Enhancing R&D, creating efficiencies, and increasing impact

Blog

Using AI to accelerate clinical trials

How available and scalable AI technologies can speed and improve clinical trials

R&D, Clinical Innovation

Perspectives

Life sciences research and development insights

Reshaping R&D innovation. Data-driven. Digitally enabled. Patient-focused.

New innovations and technologies– such as real-world evidence, data analytics, and blockchain – are helping companies improve life sciences R&D productivity.

Deloitte Insights

Enhancing clinical trial diversity

Stakeholder perspectives on advancing research through representative clinical trials

Racial and ethnic diversity among clinical trial participants is important to support science-driven strategies aimed at understanding the needs of those who are affected by the disease or condition being investigated. How can the biopharma industry achieve this? The answer lies in multistakeholder partnerships.

Analysis

Measuring the return from pharmaceutical innovation 2022

Our latest report looks at the current state of R&D returns for 15 leading biopharma companies from May 2019 to April 2020, the impact of the pandemic on R&D pipelines during 2020 and identifies lessons that can help change the R&D paradigm towards a future with higher returns.

Blog

Retail Clinics May be the Next Frontier for Clinical Trials

Could clinical trials move to grocery store and pharmacy chains?

Value, Access, & Pricing

Deloitte Insights

Rethinking market access

Delivering on the promise of therapeutic innovation

Market access strategy is critical to therapy launch success, but traditional approaches can lack nuance. Our research suggests that an archetype-based approach to enable targeted market access strategies may be more useful.

Perspectives

State drug price transparency

Operational considerations for drug pricing regulation

Operational considerations for manufacturers to understand how to remain compliant as new state drug pricing transparency legislations are enacted.

Deloitte Insights

Where will pharmacy be in 10 years?

Pharmacist of the future

As accessible and trusted health care personnel, pharmacists can play a big role in the future of health.

Blog

Channel Strategy May Be Key in Commercializing Specialty Rx | Deloitte US

Channel strategy is critically important for successful specialty pharma launches

Medical Technology of the Future

Medical Technology

The next generation of medical technology has the potential to shape the entire health care industry. Find out where Medical Technology (MedTech) transformation could take you.

Perspectives

Navigating the Future of the MedTech Industry

Deloitte’s blog series outlining MedTech industry trends, challenges, and opportunities in a changing health care marketplace.

Blog

What’s the Big Deal With 5G Anyway? The Promise (and Reality) of 5G in Medtech

8 areas 5G could enhance medical devices and services.

Analysis

Reinvigorating medtech innovation

Opportunities on the horizon

Venture capital investments in the medtech industry have declined. Find out how this may impact new innovations and life-saving treatments for patients.

Cell & Gene Therapies

Analysis

NextGen cell and gene therapy

Personalized precision medicine is here

Advancements in next-generation cell and gene therapies are fulfilling the promise of personalized medicine and attempting to cure and heal patients rather than ameliorating symptoms. Multiple approved products have been launched in global markets and the number of clinical trials continues to grow.

Blog

The Next Generation of Cell and Gene Therapies | Deloitte US

An inside look at the future of cell and gene therapy

Blog

Orchestrating a Patient-Centric Cell/Gene Ecosystem | Deloitte US

Harmonizing the patient-centric cell & gene ecosystem

Blog

Industry Working Group Finalizes Cell-Collection Labeling Standards for Cell and Gene Therapies to improve patient safety | Deloitte US

Cell and gene therapies have shown promise in their ability to cure and heal patients rather than merely treat their symptoms.

Regulatory, Legal, & Compliance

Perspectives

Never the same again: How COVID-19 created seismic change in global life sciences regulations

A global report for life sciences executives and regulators

COVID-19 accelerated global scientific and regulatory innovation and collaboration in the life sciences industry. To stretch to new limits, the momentum must continue.

Perspectives

State drug price transparency

Operational considerations for drug pricing regulation

Operational considerations for manufacturers to understand how to remain compliant as new state drug pricing transparency legislations are enacted.

Perspectives

Regulatory changes in the future of health

Engaging with regulators and staying abreast of legislative and regulatory activity will be as important as ever

Responding to new or changing regulations is a persistent challenge for health care stakeholders, and it is one that is not fading away anytime soon.

13 Apr.

Dbriefs

How health care and life sciences organizations can earn trust when trust is at a deficit

Thu. | 13 Apr. 2023 | 11:00 a.m. ET

April 13, 2023 | Join us to discover how trusted actions performed by companies, in different operating areas (domains) across the enterprise, positively impact stakeholder behavior and organizational performance.

Audit, Accounting, & Finance

Analysis

2023 Life Sciences Industry Accounting Guide

Insights and guidance on life sciences accounting issues

As COVID-19 affects major economic and financial markets, explore the key accounting considerations for the life sciences industry.

Perspectives

Audit evolved

The next generation of life sciences audit

Deloitte’s Audit Life Sciences brochure explores the evolution of life sciences and audit, by examining current key industry and accounting issues.

Perspectives

Zimmer biomet weaves innovation into internal audit

Zimmer biomet provides independent assurance

Leveraging his experience in turnarounds, Brian Thelen of Zimmer Biomet understands how to lead internal audit through complex, fast-paced, unpredictable environments.

Perspectives

AbbVie’s Rhomberg Comes Full Circle

AbbVie’s Rhomberg Comes Full Circle as Internal Audit Evolves

When Jim Rhomberg returned to lead the internal audit function at AbbVie, he knew an evolution had taken place in the function.

Quote-with-link. Do not delete! This box/component contains JavaScript that is needed on this page. This message will not be visible when page is activated.

Connect via email

Subscribe

Contact us

Contact us via our online form

Submit RFP

Submit via our online form

Services

Life sciences artificial intelligence solutions in the Age of With

Take a closer look at the artificial intelligence solutions, capabilities, and assets Deloitte offers across the life sciences value chain to enable new opportunities, help drive operational efficiency, fuel growth, and bring life-saving therapies to market faster.
Value-Based Contracting Services

Value-based contracts (VBCs) are a promising way to shift from volume to value in health care and keep pace with life sciences innovation.
Deloitte Market Access Excellence (MAx) commercial framework

The MAx Commercial framework guides life sciences companies through “must answer” choices for developing market access strategies for Biopharma manufacturers.
IT Quality Services for Life Sciences

Deloitte’s IT Quality practice helps life sciences companies to meet their needs for compliant IT quality services and mitigate IT risk.

Get in touch

Pete Lyons

National sector leader for Deloitte’s Life Sciences practice

plyons@deloitte.com

+1 617 519 1817

Dan Ressler

Principal | Deloitte Risk & Financial Advisory

dressler@deloitte.com

+1 215 299 5210

Maggie Zellers

US Life Sciences Tax Leader | Deloitte Tax LLP

mzellers@deloitte.com

+1 312 486 3621

Jeff Ellis

US & Global A&A LS Leader | LS PPD

jeellis@deloitte.com

+1 412 338 7204

@DeloitteHealth

Sharing news, research, events, and more

Join the conversation

Contact us
Search jobs
Submit RFP
Subscribe to Deloitte Insights

Global office directory US office locations

US-EN Location: United States-English

About Deloitte

About Deloitte
Client stories
My Deloitte
Deloitte Insights
Email subscriptions
Press releases
Submit RFP
US office locations
Alumni
Global office directory
Newsroom
Dbriefs webcasts
Contact us

Services

Tax
Consulting
Audit & Assurance
Deloitte Private
M&A and Restructuring
Risk & Financial Advisory
AI & Analytics
Cloud
Diversity, Equity & Inclusion

Industries

Consumer
Energy, Resources & Industrials
Financial Services
Government & Public Services
Life Sciences & Health Care
Technology, Media & Telecommunications

Careers

Careers
Students
Experienced Professionals
Job Search
Life at Deloitte
Alumni Relations

About Deloitte
Terms of Use
Privacy
Privacy Shield
Cookies
Cookie Settings
Legal Information for Job Seekers
Labor Condition Applications
Do Not Sell or Share My Personal Information

© 2023. See Terms of Use for more information.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee ("DTTL"), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as "Deloitte Global") does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the "Deloitte" name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.